Short Interest in Curative Biotechnology, Inc. (OTCMKTS:CUBT) Rises By 452.6%

Curative Biotechnology, Inc. (OTCMKTS:CUBT) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 42,000 shares, a growth of 452.6% from the June 15th total of 7,600 shares. Based on an average daily trading volume, of 520,700 shares, the days-to-cover ratio is presently 0.1 days.

Curative Biotechnology Price Performance

OTCMKTS CUBT remained flat at $0.02 during trading on Friday. The company has a fifty day moving average price of $0.02 and a two-hundred day moving average price of $0.02. Curative Biotechnology has a 1 year low of $0.00 and a 1 year high of $0.04.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.